Stock Market & Financial Investment News

News Breaks October 18, 2012 06:02 EDT STJ St. Jude Medical downgraded to Neutral from Buy at Goldman Goldman downgraded St. Jude following Q3 results citing slowing core business growth. Price target lowered to $42 from $48. News For STJ From The Last 14 Days Check below for free stories on STJ the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 11:12 EDT STJ St. Jude Medical to evaluate defibrilator lead related to reported death Subscribe for More Information May 16, 2013 08:05 EDT STJ St. Jude Medical's 3-D vessel reconstruction system approved in Europe St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform. May 14, 2013 08:09 EDT STJ St. Jude Medical announces first patient enrolled in EnligHTN III study Subscribe for More Information May 9, 2013 14:01 EDT STJ St. Jude says analysis demonstrates safety, reliability of Optim-insulated leads Subscribe for More Information 09:27 EDT STJ Leerink's medical devices analyst holds a conference call Subscribe for More Information May 8, 2013 08:09 EDT STJ St. Jude Medical announces CE Mark approval of ICDs, CRT-Ds Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.